Physician
Urology
Dr. Elie A. Benaim, MD
|
|
Give Review
Elie Benaim practices Urology. He studied medicine at University of Texas Southwestern Medical School. He received awards:"CMS Meaningful Use Stage 1 Certification" and "Super Doctor". Doctor Elie A. Benaim, MD has written publications. He has 22 publications published with PubMed. The lastest paper is: 'Effectiveness of intensified rotational combination chemotherapy for late hematologic relapse of childhood acute lymphoblastic leukemia.' Elie Benaim is registered with Medicare and accepts Medicare payments.
Publications
- Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuro...
- Encephalopathy in pediatric patients after allogeneic hematopoietic stem cell transplantation is associated with a poor prognosis.
- Enuresis in sickle cell Disease.
- Effectiveness of intensified rotational combination chemotherapy for late hematologic relapse of childhood acute lymphoblastic leukemia.
- Allogeneic bone marrow transplantation for infants with acute leukemia or myelodysplastic syndrome.
- Intraluminal crystalloids are highly associated with prostatic adenocarcinoma on concurrent biopsy specimens.
- Alpha-blockade downregulates myosin heavy chain gene expression in human benign prostatic hyperplasia.
- Impact of training level of urology residents on the detection of prostate Cancer on TRUS biopsy.
- Gleason score predicts androgen independent progression after androgen deprivation therapy.
- Change in prostate specific antigen following androgen stimulation is an independent predictor of prostate Cancer diagnosis.
- Quantifying the impact of prostate volumes, number of biopsy cores and 5alpha-reductase inhibitor therapy on the probability of prostate Cancer detection using mathema...
- Prostate-specific antigen doubling time predicts response to deferred antiandrogen therapy in men with androgen-independent prostate Cancer.
- The use of histone deacetylase inhibitor FK228 and DNA hypomethylation agent 5-azacytidine in human Bladder cancer therapy.
- Contemporary techniques and safety of cardiovascular procedures in the surgical management of Renal cell carcinoma with tumor thrombus.
- Critical analysis of Prostate-specific antigen doubling time calculation methodology.
- Pre-treatment nomogram for disease-specific survival of patients with chemotherapy-naive androgen independent prostate Cancer.
- Prognostic model of event-free survival for patients with androgen-independent Prostate carcinoma.
- The effect of combined androgen ablation on the expression of alpha1A-adrenergic receptor in the human Prostate.
- The natural history of androgen independent prostate Cancer.
- Molecular imaging in prostate Cancer.
- Nadir prostate-specific antigen as a predictor of progression to androgen-independent prostate Cancer.
Procedures Preformed
- AdRenalectomy
- Advanced Laparoscopic Surgery
- Complete Nephrectomy With Robotic Assistance
- Cystometry
- View All
Conditions Treated
- Atrophic Vaginitis
- Balanoposthitis
- Bladder Cancer
- Bladder Infection
- View All
Doctors Specialties
- Urology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- Blue Choice
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- CoreSource
- Coventry Health Care
- Group Health Cooperative
- HealthSmart
- Choice Care PPO
- Preferred PPO
- Medical Mutual of Ohio
- Medicare MCR
- Molina
- MultiPlan PPO
- PHCS Network PPO
- Old Surety Life Insurance CompanyMedicare MCR
- Thrivent Financial
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
- Universal American
Awards
- CMS Meaningful Use Stage 1 Certification
- Super Doctor
Education
-
University of Texas Southwestern Medical School -
Central University of Venezuela
Hospital
-
Medical City Dallas Hospital
Drug Facts
| NPI NUMBER | 1790748176 | |
| NPPES Provider LastName | BENAIM | |
| NPPES Provider FirstName | ELIE | |
| NPPES Provider ZIPCode | 752302505 | |
| NPPES Provider State | TX | |
| Specialty Description | Urology | |
| Total Claim Count | 1264.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 88.0 | |
| Percent Opioid Claims | 6.96 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1790748176 |
| Last Name Of The Provider | BENAIM |
| First Name Of The Provider | ELIE |
| View All |
Similar Doctors
|
Dr. Ganesh V. Raj, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Pat F. Fulgham, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vitaly Margulis, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Eric B. Smith, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joshua K. Fine, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Linda A. Baker, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Clanton B. Harrison III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Homa J. Porter II, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul B. Handel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. George P. Shropulos, MD |
|
|
Dr. Philippe E. Zimmern, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. James F. Lederer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brian A. Feagins, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steve M. Frost, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jodi Antonelli, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nathan R. Starke, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sujeet S. Acharya, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Oussama Darwish, MD |
|
|
Jacqueline D. Smith, MS
This Doctor is OpenDoctor Recommended.
|